Post-IPO Equity Pharmaceutical Companies

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

Phathom Pharmaceuticals is a biopharmaceutical company.

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Belite Bio is a clinical stage biopharmaceutical drug development company.

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.